Alcohol Use Disorder: Sunobinop Study

We are testing whether Sunobinop can help reduce heavy drinking days for individuals with alcohol use disorder. This study aims to understand its effects on overall alcohol consumption and cravings.

≤3 months Efficacy phase (II)Cost Reimbursement Investigational Medicines OralPsychiatry

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Panobinostat

Panobinostat is a substance used to treat certain cancers by stopping cancer cell growth, commonly for advanced multiple myeloma.

Perindopril Tosilate

Perindopril Tosilate helps lower high blood pressure and reduces strain on the heart by relaxing blood vessels.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Sunobinop

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Bio Terra Med S.R.L

Psychiatry

Bucharest, Romania

C.M.I Dr. Popa Andreea

Psychiatry

Bucharest, Romania

Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila

Psychiatry

Bucharest, Romania

Sponsor: Imbrium Therapeutics LP

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.